| Dr Hilleary Nicole Recchio, AUD | |
|
2002 Medical Pkwy Ste 230, Annapolis, MD 21401-3282 | |
| (410) 266-3900 | |
| Not Available |
| Full Name | Dr Hilleary Nicole Recchio |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 2002 Medical Pkwy Ste 230, Annapolis, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659654549 | NPI | - | NPPES |
| Provider Name | Hearing Healthcare, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1942220744 PECOS PAC ID: 7719144021 Enrollment ID: O20120127000844 |
News Archive
A team of French and Brazilian researchers warn that chikungunya virus is poised to invade, and become epidemic in the Americas according to research published ahead of print in the Journal of Virology.
A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins today. Financed by the European Commission, the European AIDS Vaccine Initiative (EAVI2020) brings together leading HIV researchers from public organisations and biotech companies from across Europe, Australia, Canada and the USA in a focused effort to develop protective and therapeutic HIV vaccines.
It has been reported that the incidence of testicular cancer in the Caucasian population in the United States increased during most of the last half of the 20th Century, but information on trends in the occurrence of prepubertal testicular cancer is lacking in the literature.
Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hilleary Nicole Recchio, AUD 2002 Medical Pkwy Ste 230, Annapolis, MD 21401-3282 Ph: (410) 266-3900 | Dr Hilleary Nicole Recchio, AUD 2002 Medical Pkwy Ste 230, Annapolis, MD 21401-3282 Ph: (410) 266-3900 |
News Archive
A team of French and Brazilian researchers warn that chikungunya virus is poised to invade, and become epidemic in the Americas according to research published ahead of print in the Journal of Virology.
A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins today. Financed by the European Commission, the European AIDS Vaccine Initiative (EAVI2020) brings together leading HIV researchers from public organisations and biotech companies from across Europe, Australia, Canada and the USA in a focused effort to develop protective and therapeutic HIV vaccines.
It has been reported that the incidence of testicular cancer in the Caucasian population in the United States increased during most of the last half of the 20th Century, but information on trends in the occurrence of prepubertal testicular cancer is lacking in the literature.
Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.
› Verified 2 days ago
Dr. Brittany Bailey Tuscany, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy Ste 230, Annapolis, MD 21401 Phone: 410-266-3900 | |
Samantha Johanna Mcmahon, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy Ste 230, Annapolis, MD 21401 Phone: 410-266-3900 Fax: 410-266-9245 | |
Carrie Veneman Davis, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 2002 Medical Pkwy, Suite 230, Annapolis, MD 21401 Phone: 410-266-3900 | |
Chelsea Donahue, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 600 Ridgely Ave Ste 110, Annapolis, MD 21401 Phone: 410-647-7795 Fax: 410-315-8823 | |
Julia Elizabeth Fitzer, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 2530 Riva Rd, Ste 309, Annapolis, MD 21401 Phone: 410-266-7540 | |
Dr. Megan Espinosa, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1125 West St Ste 601, Annapolis, MD 21401 Phone: 443-716-5016 | |
Dr. Danielle Mills, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 2525 Riva Rd Ste 102, Annapolis, MD 21401 Phone: 410-671-5656 Fax: 443-272-4990 |